Biocon Biologics and Viatris’s Semglee preferred on Express Scripts’ largest formulary in US Read more
Inter-changeable designation for Semglee in the US is a milestone achievement for Biocon Biologics Read more
Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30 countries Read more
Biocon and Voluntis deal to transform insulin biosimilars personalised care through digital therapeutics: GlobalData Read more
Biocon Biologics receives EU GMP Certification for multiple Biosimilars manufacturing facilities in Bengaluru Read more